| CTC Research Brings Big Steps For CIK Therapy |
 |
|
In the coming weeks, CTC researchers plan to publicly announce the cutting-edge progress they have made in the application of CIK therapy. In recent research, CIK cells cultured from umbilical cord blood were used in animal trials. In these trials, the new CIK cells effectively killed the cancer cells 80% of the time.
There is still more testing to be done, as animals are quite different than complex human bodies. However, umbilical cord CIK cells are showing great promise in the near future for human application. Dosage can greatly affect effectiveness, and researchers are currently testing variables regarding dosage, time, and interval of injection. Thus far, CTC researchers have successfully used CIK to kill 9 types of cancer:
|
